Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
September 4, 2012
Patent Application Number
12090847
Date Filed
October 17, 2006
Patent Citations Received
Patent Primary Examiner
Patent abstract
Disclosed herein are compounds, compositions and methods for modulating the expression of LMNA in a cell, tissue or animal. Also provided are methods of target validation. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders. Further provided are methods of identifying cis splicing regulatory elements of a selected mRNA using the disclosed compounds.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
